
    
      Four cycles of treatment are proposed at 28 day intervals in an ambulatory setting

      Cycle 1 :

        -  Cytarabine 10 mg /m2/day subcutaneous injection for 14 days

        -  Bortézomib 1,5mg/m2 days 1,4,8,11

      Cycles 2, 3, 4 :

        -  Cytarabine 20 mg /m2/j subcutaneous injections for 14 days

        -  Bortézomib 1,5mg/m2 days 1,4,8,11

      Bone marrow aspirates are evaluated just before the first cycle, after the second and after
      the fourth cycles

      Responding patients may continue the treatment for 2 further cycles
    
  